These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2516430)

  • 1. Treatment of chronic non-A non-B hepatitis with human interferon beta: a preliminary study.
    Kiyosawa K; Sodeyama T; Nakano Y; Yoda H; Tanaka E; Hayata T; Tsuchiya K; Yousuf M; Furuta S
    Antiviral Res; 1989 Oct; 12(3):151-61. PubMed ID: 2516430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
    Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M
    Gastroenterol Jpn; 1990 Feb; 25(1):70-7. PubMed ID: 2106467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.
    Kakumu S; Arao M; Yoshioka K; Ichimiya H; Murase K; Aoi T; Kusakabe A
    Am J Gastroenterol; 1989 Jan; 84(1):40-5. PubMed ID: 2521421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
    Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
    Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
    Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
    N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
    Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
    Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.
    Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E
    Am J Gastroenterol; 1990 Jan; 85(1):24-9. PubMed ID: 1688684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
    Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
    Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.
    Echizen H; Ohta Y; Shirataki H; Tsukamoto K; Umeda N; Oda T; Ishizaki T
    J Clin Pharmacol; 1990 Jun; 30(6):562-7. PubMed ID: 2113064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
    Serfaty L; Chazouillères O; Pawlotsky JM; Andreani T; Pellet C; Poupon R
    Gastroenterology; 1996 Jan; 110(1):291-5. PubMed ID: 8536870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen.
    Brunetto MR; Oliveri F; Rocca G; Criscuolo D; Chiaberge E; Capalbo M; David E; Verme G; Bonino F
    Hepatology; 1989 Aug; 10(2):198-202. PubMed ID: 2663695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of response to interferon in patients with chronic active hepatitis C, and evidence that this improves hepatic metabolic function.
    Farrell GC; Lin R; Coverdale S
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():243-6. PubMed ID: 1909273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.